18th CANDIAN MELANOMA CONFERENCE 2024: Long-Term Toxicities of Immunotherapeutics – Dr. David F. McDermott

18th CANDIAN MELANOMA CONFERENCE 2024: Long-Term Toxicities of Immunotherapeutics – Dr. David F. McDermott

Canadian Melanoma Conference 2024
Icon Objectives

Learning Objectives

  1. Describe key clinical trial data from 2023 in the management of melanoma and understand the impact on Canadian practices.
  2. Understand the latest strategies in melanoma as they pertain to medical oncology, pathology, radiation, and surgery.
  3. Implement approaches that maximize patient standard of care in melanoma
Icon Chair Speaker

Co-Chairs

Dr. Vanessa Bernstein
Dr. Teresa Petrella

Icon Chair Speaker

Speakers

Dr. David F. McDermott

Tagged